{"id":67526,"date":"2022-04-13T08:00:00","date_gmt":"2022-04-13T01:00:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2022041308000067526"},"modified":"2022-04-13T19:39:07","modified_gmt":"2022-04-13T11:39:07","slug":"vistagen%e4%b8%8e%e8%94%bc%e7%9d%a6%e5%8c%bb%e7%96%97%e5%90%88%e4%bd%9c%e5%ae%8c%e6%88%90ph94b-palisade%e5%85%a8%e7%90%83%e4%b8%89%e6%9c%9f%e4%b8%b4%e5%ba%8a%e8%af%95%e9%aa%8c%e7%94%b3%e8%af%b7","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2022041308000067526","title":{"rendered":"VistaGen\u4e0e\u853c\u7766\u533b\u7597\u5408\u4f5c\u5b8c\u6210PH94B PALISADE\u5168\u7403\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7"},"content":{"rendered":"

\u53cc\u65b9\u8ba1\u5212\u4e8e 2022 \u5e74\u4e0b\u534a\u5e74\u542f\u52a8 PH94B \u7528\u4e8e\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u793e\u4ea4\u7126\u8651\u969c\u788d (SAD) \u7684\u5168\u7403\u7814\u7a76<\/p>\n

\u8bd5\u9a8c\u65e8\u5728\u652f\u6301 PH94B \u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u4ee5\u5916\u5176\u4ed6\u5e02\u573a\u7684\u5546\u4e1a\u5316<\/p>\n

\u4e0a\u6d77<\/span>2022\u5e744\u670813\u65e5<\/span> \/\u7f8e\u901a\u793e\/ — VistaGen Therapeutics, Inc. (\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aVTGN\uff09(VistaGen) \u548c\u853c\u7766\u533b\u7597\uff08AffaMed Therapeutics\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u7ecf\u5b8c\u6210\u76f8\u5173\u51c6\u5907\u5de5\u4f5c\uff0c\u5373\u5c06\u542f\u52a8\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u7684 PALISADE \u5168\u7403\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30 PH94B\uff08\u853c\u7766\u533b\u7597 AM005\uff09\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u793e\u4ea4\u7126\u8651\u969c\u788d (SAD) \u6210\u4eba\u60a3\u8005\u65f6\u7684\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u7814\u7a76\u8bbe\u8ba1\u57fa\u4e8e VistaGen \u6b63\u5728\u7f8e\u56fd\u8fdb\u884c\u7684 PH94B PALISADE-1 \u548c PALISADE-2 \u4e09\u671f\u7814\u7a76\u3002PALISADE \u5168\u7403\u7814\u7a76\u7684\u4e3b\u8981\u76ee\u7684\u662f\u4e3a PH94B \u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u4ee5\u5916\u5176\u4ed6\u5e02\u573a\u7684\u6f5c\u5728\u5546\u4e1a\u5316\u63d0\u4f9b\u652f\u6301\u3002<\/p>\n

\u57fa\u4e8e PH94B \u73b0\u6709\u9488\u5bf9 SAD \u7684\u65b0\u836f\u7814\u7a76 (IND) \u7533\u8bf7\uff0cVistaGen \u6700\u8fd1\u5411\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 (FDA) \u63d0\u4ea4\u4e86 PALISADE \u5168\u7403\u7814\u7a76\u65b9\u6848\uff1b\u853c\u7766\u533b\u7597\u4e5f\u4e8e\u6b64\u524d\u6536\u5230\u4e86\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40 (NMPA) \u5bf9\u5176\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7 (CTA) \u7684\u76d1\u7ba1\u8bb8\u53ef\u3002\u4e2d\u7f8e\u4e24\u5730\u7684\u4e34\u5e8a\u8bb8\u53ef\u5171\u540c\u4e3a 2022 \u5e74\u4e0b\u534a\u5e74\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u542f\u52a8 PALISADE \u5168\u7403\u7814\u7a76\u5960\u5b9a\u4e86\u57fa\u7840\u3002\u9664\u6b64\u4e4b\u5916\uff0c\u4e24\u5bb6\u516c\u53f8\u8fd8\u8ba1\u5212\u5728\u52a0\u62ff\u5927\u3001\u58a8\u897f\u54e5\u548c\u97e9\u56fd\u542f\u52a8\u8fd9\u9879\u4e09\u671f\u7814\u7a76\u3002\u4f5c\u4e3a\u4e00\u6b3e\u65e0\u5473\u3001\u5feb\u901f\u8d77\u6548\u7684\u4fe1\u606f\u7d20\u9f3b\u55b7\u5242\uff0cPH94B \u5177\u6709\u72ec\u7279\u7684\u6f5c\u5728\u4f5c\u7528\u673a\u5236\uff0c\u53ef\u7528\u4e8e\u6210\u4eba SAD \u60a3\u8005\u5728\u7126\u8651\u65f6\u8fdb\u884c\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u3002\u5728\u4f5c\u7528\u65b9\u5f0f\u4e0a\uff0cPH94B \u4e0e\u76ee\u524d FDA \u6216 NMPA \u6279\u51c6\u7528\u4e8e\u6cbb\u7597 SAD \u7684\u7597\u6cd5\u5747\u4e0d\u540c\u3002<\/p>\n

\u201c\u80fd\u591f\u5728\u5168\u7403\u6700\u5927\u7684\u4e24\u4e2a\u533b\u836f\u5e02\u573a\u542f\u52a8 PALISADE \u5168\u7403\u7814\u7a76\uff0c\u6211\u4eec\u5bf9\u56e2\u961f\u53d6\u5f97\u7684\u91cd\u5927\u8fdb\u5c55\u611f\u5230\u975e\u5e38\u9ad8\u5174\u3002\u201dVistaGen\u9996\u5e2d\u6267\u884c\u5b98 Shawn Singh<\/span> \u8868\u793a\uff0c\u201c\u853c\u7766\u533b\u7597\u6210\u529f\u83b7\u5f97 NMPA \u7684\u8bb8\u53ef\uff0c\u8fd9\u66f4\u575a\u5b9a\u4e86\u6211\u4eec\u5bf9\u853c\u7766\u533b\u7597\u4f5c\u4e3a PH94B \u4e2d\u56fd\u6700\u4f73\u5408\u4f5c\u4f19\u4f34\u7684\u4fe1\u5ff5\u3002\u5728\u7ee7\u7eed\u63a8\u8fdb PH94B \u7528\u4e8e\u6025\u6027\u7ed9\u836f\u6cbb\u7597 SAD \u6210\u4eba\u7126\u8651\u7684\u91cd\u8981\u540e\u671f\u4e34\u5e8a\u9879\u76ee\u4e2d\uff0c\u6211\u4eec\u5bf9\u53cc\u65b9\u5408\u4f5c\u5145\u6ee1\u4fe1\u5fc3\u3002VistaGen \u5c06\u7ee7\u7eed\u4e0d\u61c8\u52aa\u529b\uff0c\u4e3a\u5168\u7403\u6570\u767e\u4e07\u9700\u8981\u66f4\u597d\u3001\u66f4\u5b89\u5168\u548c\u66f4\u5feb\u8d77\u6548\u7597\u6cd5\u7684\u7126\u8651\u969c\u788d\u60a3\u8005\u63d0\u4f9b\u53d8\u9769\u6027\u7684\u7cbe\u795e\u5065\u5eb7\u6cbb\u7597\u836f\u7269\u3002\u201d<\/p>\n

\u853c\u7766\u533b\u7597\u9996\u5e2d\u6267\u884c\u5b98\u8d75\u5927\u5c27\u535a\u58eb\u8868\u793a\uff1a\u201c\u4e2d\u56fd\u836f\u76d1\u5c40\u5bf9 PALISADE \u5168\u7403\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\uff0c\u662f\u6211\u4eec\u5728\u63a8\u8fdb\u795e\u7ecf\u548c\u7cbe\u795e\u75be\u75c5\u9886\u57df\u4ea7\u54c1\u7ec4\u5408\u8fdb\u7a0b\u4e2d\u53d6\u5f97\u7684\u53c8\u4e00\u91cd\u5927\u91cc\u7a0b\u7891\u3002\u4e2d\u56fd\u3001\u97e9\u56fd\u548c\u4e1c\u5357\u4e9a\u5730\u533a\u7684 SAD \u60a3\u8005\u6b63\u5728\u6301\u7eed\u589e\u957f\uff0c\u6211\u4e3a\u56e2\u961f\u80fd\u591f\u4e13\u6ce8\u5411\u60a3\u8005\u63d0\u4f9b\u521b\u65b0\u6cbb\u7597\u65b9\u6848\u548c\u6240\u53d6\u5f97\u7684\u6210\u7ee9\u6df1\u611f\u81ea\u8c6a\u3002\u611f\u8c22 VistaGen \u5728\u5411\u7f8e\u56fd FDA \u63d0\u4ea4 PH94B IND \u7533\u8bf7\u4e2d\u7684\u91cd\u8981\u8d21\u732e\uff0c\u540c\u65f6\u4e5f\u611f\u8c22 NMPA \u5bf9\u8fd9\u9879\u4e09\u671f\u7814\u7a76\u91cd\u8981\u6027\u7684\u8ba4\u53ef\uff0c\u5e76\u52a0\u901f\u5b8c\u6210\u4e86\u76f8\u5173 CTA \u7684\u6279\u51c6\u3002\u6211\u4eec\u671f\u5f85\u5728\u4eca\u5e74\u665a\u4e9b\u65f6\u5019\u5b9e\u73b0\u53d7\u8bd5\u8005\u7ed9\u836f\u3002\u201d<\/p>\n

2020\u5e746\u6708\uff0c\u853c\u7766\u533b\u7597\u4e0e VistaGen Therapeutics \u8fbe\u6210\u6218\u7565\u8bb8\u53ef\u548c\u5408\u4f5c\u534f\u8bae\uff0c\u83b7\u5f97\u5728\u4e2d\u56fd\u3001\u97e9\u56fd\u548c\u4e1c\u5357\u4e9a\u5730\u533a\u8fdb\u884c PH94B \u4e34\u5e8a\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u7684\u6743\u76ca\u3002<\/p>\n

\u622a\u81f3\u76ee\u524d\uff0c\u7f8e\u56fd\u548c\u4e2d\u56fd\u7684\u533b\u836f\u76d1\u7ba1\u5f53\u5c40\u5c1a\u672a\u6279\u51c6\u4efb\u4f55\u7528\u4e8e\u6025\u6027\u7ed9\u836f\uff08\u6309\u9700\uff09\u6cbb\u7597 SAD \u6210\u4eba\u60a3\u8005\u7126\u8651\u7684\u836f\u7269\u3002\u5728\u7f8e\u56fd\uff0cSAD \u901a\u5e38\u4f7f\u7528 FDA \u6279\u51c6\u7684\u67d0\u4e9b\u6297\u6291\u90c1\u836f\u6cbb\u7597\uff0c\u8fd9\u4e9b\u6297\u6291\u90c1\u836f\u8d77\u6548\u7f13\u6162\uff08\u9700\u8981\u6570\u5468\u65f6\u95f4\uff09\uff0c\u6cbb\u7597\u83b7\u76ca\u6709\u9650\u3002\u82ef\u4e8c\u6c2e\u5353\u7c7b\u836f\u7269\u672a\u83b7\u5f97 FDA \u6279\u51c6\u7528\u4e8e\u6cbb\u7597 SAD\uff0c\u4e3a\u9002\u5e94\u75c7\u5916\u7528\u836f\u3002\u6297\u6291\u90c1\u836f\u548c\u82ef\u4e8c\u6c2e\u5353\u7c7b\u836f\u7269\u90fd\u6709\u5df2\u77e5\u7684\u526f\u4f5c\u7528\u548c\u5b89\u5168\u95ee\u9898\uff0c\u8fd9\u53ef\u80fd\u4f7f\u8bb8\u591a SAD \u60a3\u8005\u62d2\u7edd\u4f7f\u7528\u3002<\/p>\n

\u5173\u4e8e <\/b>PALISADE \u5168\u7403\u7814\u7a76<\/b><\/p>\n

PALISADE \u5168\u7403\u7814\u7a76\u662f\u4e00\u9879\u968f\u673a\u3001\u591a\u533a\u57df\u3001\u591a\u4e2d\u5fc3\u3001\u53cc\u76f2\u3001\u5b89\u6170\u5242\u5bf9\u7167\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u53c2\u7167\u4e86 VistaGen \u76ee\u524d\u6b63\u5728\u7f8e\u56fd\u5f00\u5c55\u7684 PALISADE-1 \u548c PALISADE-2 \u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002PALISADE \u5168\u7403\u7814\u7a76\u4e34\u5e8a\u4e2d\u5fc3\u6db5\u76d6\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u52a0\u62ff\u5927\u3001\u58a8\u897f\u54e5\u548c\u97e9\u56fd\uff0c\u8ba1\u5212\u62db\u52df\u5927\u7ea6208\u540d\u6210\u4eba\u53d7\u8bd5\u8005\u3002\u54e5\u4f26\u6bd4\u4e9a\u5927\u5b66\u7cbe\u795e\u75c5\u5b66\u4e13\u5bb6\u3001\u7ebd\u7ea6\u5dde\u7cbe\u795e\u75c5\u7814\u7a76\u6240\u7126\u8651\u969c\u788d\u4e2d\u5fc3\u524d\u4e3b\u4efb\u548c\u521b\u59cb\u4eba\u3001\u7ebd\u7ea6\u5e02\u533b\u5b66\u7814\u7a76\u7f51\u7edc\u4e3b\u4efb\u3001Liebowitz \u793e\u4ea4\u7126\u8651\u91cf\u8868 (LSAS) \u53d1\u660e\u4eba Michael Liebowitz<\/span> \u535a\u58eb\u62c5\u4efb\u8be5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4e3b\u8981\u7814\u7a76\u8005\u3002<\/p>\n

PALISADE-1\u3001PALISADE-2 \u548c PALISADE \u5168\u7403\u4e09\u671f\u7814\u7a76\u7684\u8bbe\u8ba1\u4e0e\u5df2\u53d1\u8868\u7684 PH94B \u7528\u4e8e\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u6210\u4eba SAD \u60a3\u8005\u7684\u4e8c\u671f\u7814\u7a76\u57fa\u672c\u76f8\u4f3c\u3002\u8be5\u4e8c\u671f\u7814\u7a76\u53d1\u73b0 PH94B \u80fd\u5feb\u901f\u964d\u4f4e\u516c\u5f00\u6f14\u8bb2\u573a\u5408\u5f15\u8d77\u7684\u7126\u8651\uff0815\u5206\u949f\u5185\uff09(p=0.002)\u3002VistaGen \u548c\u853c\u7766\u533b\u7597\u8ba1\u5212\u4e8e 2022 \u5e74\u4e0b\u534a\u5e74\u5f00\u59cb\u62db\u52df PALISADE \u5168\u7403\u7814\u7a76\u53d7\u8bd5\u8005\uff0c\u9884\u8ba1 2024 \u5e74\u4e2d\u671f\u83b7\u5f97\u5173\u952e\u4e34\u5e8a\u7ed3\u679c\u3002PALISADE-1 \u548c PALISADE-2 \u4e24\u9879\u7814\u7a76\u76ee\u524d\u6b63\u5728\u8fdb\u884c\uff0c\u7814\u7a76\u7ed3\u679c\u5c06\u7528\u4e8e\u652f\u6301 VistaGen \u5411 FDA \u63d0\u4ea4 PH94B \u65b0\u836f\u7533\u8bf7 (NDA)\u3002PALISADE \u5168\u7403\u7814\u7a76\u72ec\u7acb\u4e8e\u4e0a\u8ff0\u4e24\u9879\u7814\u7a76\uff0c\u4e3b\u8981\u76ee\u7684\u662f\u4e3a\u5728\u7f8e\u56fd\u4ee5\u5916\u7684\u4e2d\u56fd\u548c\u5176\u5b83\u5e02\u573a\u8fdb\u884c\u76d1\u7ba1\u9012\u4ea4\u63d0\u4f9b\u652f\u6301\u3002<\/p>\n

\u5173\u4e8e <\/b>PH94B<\/b>\uff08\u853c\u7766\u533b\u7597<\/b>AM005\uff09<\/b><\/p>\n

PH94B \u662f\u5feb\u901f\u8d77\u6548\uff08\u7ea610-15\u5206\u949f\uff09\u7684\u9996\u521b\u4fe1\u606f\u7d20\u9f3b\u55b7\u5242\uff0c\u76ee\u524d\u6b63\u5728\u5f00\u5c55\u7528\u4e8e\u6cbb\u7597\u6210\u4eba SAD \u7684\u4e34\u5e8a\u8bc4\u4f30\u3002\u4fe1\u606f\u7d20\u662f\u65e0\u5473\u7684\u5408\u6210\u795e\u7ecf\u6d3b\u6027\u7c7b\u56fa\u9187\uff0c\u4e3a\u5fae\u514b\u5242\u91cf\u9f3b\u5185\u7ed9\u836f\uff0c\u4e0e\u9f3b\u8154\u5185\u5316\u5b66\u611f\u89c9\u7ec6\u80de\u4e0a\u7684\u53d7\u4f53\u7ed3\u5408\uff0c\u53ef\u5f71\u54cd\u8fb9\u7f18\u674f\u4ec1\u6838\u800c\u65e0\u5168\u8eab\u5438\u6536\u3002\u5176\u72ec\u7279\u4f5c\u7528\u673a\u5236\u5b8c\u5168\u4e0d\u540c\u4e8e\u76ee\u524d\u5305\u62ec\u82ef\u4e8c\u6c2e\u7c7b\u836f\u7269\u5728\u5185\u7684\u6240\u6709\u6297\u7126\u8651\u836f\u7269\uff0c\u4e0d\u6d89\u53ca GABA-A \u53d7\u4f53\u7684\u76f4\u63a5\u6fc0\u6d3b\u6216\u4e0e\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u795e\u7ecf\u5143\u53d7\u4f53\u7684\u7ed3\u5408\uff0c\u8fdb\u800c\u6700\u5927\u9650\u5ea6\u5730\u51cf\u5c11\u4e86\u6f5c\u5728\u7684\u5168\u8eab\u66b4\u9732\uff0c\u8fd9\u8868\u660e PH94B \u53ef\u4ee5\u5b9e\u73b0\u5feb\u901f\u6297\u7126\u8651\u4f5c\u7528\uff0c\u800c\u4e0d\u9700\u8981\u5168\u8eab\u6444\u53d6\u6216\u5f15\u8d77\u82ef\u4e8c\u6c2e\u5353\u7c7b\u7684\u526f\u4f5c\u7528\u548c\u5b89\u5168\u6027\u95ee\u9898\u3002\u76ee\u524d\uff0cPH94B \u5c1a\u672a\u83b7\u5f97 FDA\u3001NMPA \u6216\u4efb\u4f55\u5176\u4ed6\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u7528\u4e8e\u4e34\u5e8a\u7814\u7a76\u4e4b\u5916\u7684\u60a3\u8005\u3002\u9664 PALISADE \u5168\u7403\u7814\u7a76\uff0cVistaGen \u6b63\u5728\u4e00\u9879\u4e09\u671f\u4e34\u5e8a\u7814\u7a76\u4e2d\u8bc4\u4f30 PH94B \u7684\u957f\u671f\u5b89\u5168\u6027\uff0c\u7ed3\u679c\u7528\u4e8e\u652f\u6301 VistaGen \u5411 FDA \u63d0\u4ea4NDA\u3002FDA \u5df2\u6388\u4e88 PH94B \u4f5c\u4e3a SAD \u6f5c\u5728\u6cbb\u7597\u65b9\u6cd5\u7684\u5f00\u53d1\u5feb\u901f\u901a\u9053\u3002<\/p>\n

\u5173\u4e8e\u793e\u4ea4\u7126\u8651\u969c\u788d <\/b>(SAD)<\/b><\/p>\n

\u5168\u7403\u67091.88\u4ebf\u4eba\u53d7\u793e\u4ea4\u7126\u8651\u969c\u788d\u5f71\u54cd\uff0c\u5176\u4e2d\u7f8e\u56fd\u8fbe2370\u4e07\u4eba\uff0c\u800c\u4e2d\u56fd\u5219\u81f3\u5c11\u4e3a1130\u4e07\u4eba\u30021,2,3 <\/sup>\u6839\u636e\u7f8e\u56fd\u56fd\u5bb6\u536b\u751f\u7814\u7a76\u9662\u7684\u6570\u636e\uff0cSAD \u5728\u7f8e\u56fd\u662f\u7ee7\u6291\u90c1\u75c7\u548c\u836f\u7269\u6ee5\u7528\u540e\u7b2c\u4e09\u5927\u6700\u5e38\u89c1\u7684\u7cbe\u795e\u75be\u75c5\u3002SAD \u4f1a\u5f71\u54cd\u5de5\u4f5c\u3001\u5b66\u4e60\u53ca\u5176\u4ed6\u65e5\u5e38\u6d3b\u52a8\u3002\u76ee\u524d\uff0cFDA \u6216 NMPA \u5747\u672a\u6279\u51c6\u4efb\u4f55\u7528\u4e8e SAD \u6025\u6027\u7ed9\u836f\u6cbb\u7597\u7684\u5feb\u901f\u8d77\u6548\u836f\u7269\u3002<\/p>\n

\u5173\u4e8e <\/b>VistaGen<\/b><\/p>\n

VistaGen\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aVTGN\uff09\u662f\u4e00\u5bb6\u5904\u4e8e\u540e\u671f\u4e34\u5e8a\u9636\u6bb5\u3001\u4ee5\u795e\u7ecf\u7cfb\u7edf\u4e3a\u91cd\u70b9\u7684\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u6539\u53d8\u7126\u8651\u969c\u788d\u3001\u6291\u90c1\u969c\u788d\u548c\u5176\u4ed6\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u7684\u6cbb\u7597\u524d\u666f\u3002\u516c\u53f8\u6b63\u5728\u63a8\u8fdb\u5177\u6709\u6f5c\u529b\u7684\u6cbb\u7597\u65b9\u6cd5\uff0c\u4e0e\u76ee\u524d\u53ef\u7528\u7684\u6cbb\u7597\u65b9\u6cd5\u76f8\u6bd4\uff0c\u8fd9\u4e9b\u6cbb\u7597\u65b9\u6cd5\u8d77\u6548\u66f4\u5feb\uff0c\u526f\u4f5c\u7528\u66f4\u5c11\uff0c\u5b89\u5168\u6027\u66f4\u9ad8\u3002 \u202fVistaGen \u4e3b\u8981\u5019\u9009\u836f\u7269\u7684\u9002\u5e94\u75c7\u4e3a\u4e0d\u540c\u5f62\u5f0f\u7684\u7126\u8651\u969c\u788d\u548c\u6291\u90c1\u969c\u788d\u3002\u4f5c\u4e3a\u65e0\u5473\u7684\u795e\u7ecf\u6d3b\u6027\u7c7b\u56fa\u9187\uff0c\u76f8\u5173\u836f\u7269\u5c5e\u4e8e\u540d\u4e3a "\u4fe1\u606f\u7d20"\u7684\u521b\u65b0\u7c7b\u4ea7\u54c1\uff0c\u53ef\u4e0e\u9f3b\u8154\u5185\u5316\u5b66\u611f\u89c9\u795e\u7ecf\u5143\u53d7\u4f53\u7ed3\u5408\uff0c\u8fdb\u800c\u5f71\u54cd\u8fb9\u7f18\u674f\u4ec1\u6838\uff0c\u5e76\u907f\u514d\u4e86\u60a3\u8005\u5168\u8eab\u6444\u53d6\u6216\u76f4\u63a5\u4f5c\u7528\u4e8e\u5927\u8111\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u795e\u7ecf\u5143\u3002VistaGen \u7684\u4e3b\u8981\u5728\u7814\u4ea7\u54c1 PH94B \u662f\u4e00\u79cd\u9f3b\u8154\u7ed9\u836f\u55b7\u96fe\u5242\uff0c\u76ee\u524d\u6b63\u5728\u7f8e\u56fd\u8fdb\u884c\u591a\u9879\u4e09\u671f\u8bd5\u9a8c\uff0c\u9884\u8ba1\u5c06\u5728 2022 \u5e74\u83b7\u5f97\u4e34\u5e8a\u7ed3\u679c\u3002\u82e5\u6b63\u5728\u8fdb\u884c\u7684\u4e09\u671f\u7814\u7a76\u83b7\u5f97\u6210\u529f\uff0cPH94B \u6709\u671b\u6210\u4e3a\u83b7 FDA \u6279\u51c6\u7684\u9996\u4e2a\u5feb\u901f\u8d77\u6548\u7684\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u6210\u4eba\u793e\u4ea4\u7126\u8651\u969c\u788d\u7684\u836f\u7269\u3002VistaGen \u62e5\u6709\u4e00\u652f\u7ecf\u9a8c\u4e30\u5bcc\u7684\u9886\u5bfc\u56e2\u961f\uff0c\u8fd8\u6709\u5c06\u4e8e\u8fd1\u671f\u548c\u8fdc\u671f\u83b7\u5f97\u91cc\u7a0b\u7891\u4e14\u8fdb\u5ea6\u7a33\u5b9a\u7684\u4e34\u5e8a\u9879\u76ee\uff0c\u516c\u53f8\u5bf9\u6539\u53d8\u7cbe\u795e\u5065\u5eb7\u62a4\u7406\u548c\u91cd\u65b0\u5b9a\u4e49\u7126\u8651\u969c\u788d\u548c\u6291\u90c1\u969c\u788d\u7597\u6cd5\u5145\u6ee1\u4fe1\u5fc3\u3002\u656c\u8bf7\u8bbf\u95eewww.VistaGen.com\u3002 <\/p>\n

\u5173\u4e8e\u853c\u7766\u533b\u7597<\/b><\/p>\n

\u853c\u7766\u533b\u7597\u662f\u4e00\u5bb6\u5904\u4e8e\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u533b\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u9769\u65b0\u6027\u836f\u7269\u3001\u6570\u5b57\u7597\u6cd5\u548c\u533b\u836f\u5668\u68b0\u4ea7\u54c1\uff0c\u4ee5\u6ee1\u8db3\u5927\u4e2d\u534e\u5730\u533a\u548c\u5168\u7403\u60a3\u8005\u5728\u773c\u79d1\u3001\u795e\u7ecf\u548c\u7cbe\u795e\u7cfb\u7edf\u75be\u75c5\u6cbb\u7597\u9886\u57df\u5c1a\u672a\u6ee1\u8db3\u7684\u5173\u952e\u533b\u7597\u9700\u6c42\u3002\u853c\u7766\u533b\u7597\u7684\u7ba1\u7406\u56e2\u961f\u62e5\u6709\u5168\u9762\u7684\u4e13\u4e1a\u77e5\u8bc6\u548c\u884c\u4e1a\u7ecf\u9a8c\uff0c\u5e76\u5148\u540e\u5728\u4e2d\u56fd\u53ca\u5168\u7403\u9886\u5148\u8de8\u56fd\u751f\u7269\u5236\u836f\u516c\u53f8\u62c5\u4efb\u9ad8\u7ea7\u7ba1\u7406\u804c\u52a1\uff0c\u6210\u529f\u63a8\u8fdb\u548c\u4e3b\u5bfc\u521b\u65b0\u836f\u7269\u53d1\u73b0\u3001\u4e34\u5e8a\u5f00\u53d1\u3001\u6ce8\u518c\u4e8b\u52a1\u3001\u4e1a\u52a1\u62d3\u5c55\u3001\u751f\u4ea7\u5236\u9020\u548c\u5546\u4e1a\u8fd0\u8425\u4e1a\u52a1\u3002\u4e3a\u7b26\u5408\u4ea7\u54c1\u7ec4\u5408\u7684\u547d\u540d\u60ef\u4f8b\uff0c\u853c\u7766\u533b\u7597\u5728\u76f8\u5173\u7533\u8bf7\u548c\u6750\u6599\u4e2d\u5c06 PH94B \u79f0\u4e3a AM005\u3002<\/p>\n

\u53c2\u8003\u6587\u732e\uff1a<\/i>
1. Kantar Health. September 2020. National Health and Wellness Survey (NHWS), 2020. [US]. Malvern, PA.<\/i>
2. Stein, D.J., Lim, C.C.W., Roest, A.M. et al. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med 15, 143 (2017).<\/i>
3. Frost & Sullivan. January 2022. Global Market Study of CNS and Opthalmic Treatment Market, 2022. Shanghai, China<\/span>.<\/i><\/p>\n

\u8054\u7cfb\u65b9\u5f0f<\/u><\/b> <\/p>\n

\u5a92\u4f53\u54a8\u8be2<\/i><\/b> 
\u853c\u7766\u533b\u7597\u8054\u7cfb\u4eba
<\/i>Glacier Qin
\u516c\u5171\u5173\u7cfb\u526f\u603b\u76d1
Glacier.qin@affamed.com<\/a>
+86 (21) 5250 8611<\/p>\n

VistaGen \u8054\u7cfb\u4eba
<\/i>Chantal Allan 
Sam Brown Inc. 
chantalallan@sambrown.com<\/a><\/u> 
(805) 242-3080 <\/p>\n

\u6295\u8d44\u8005\u54a8\u8be2<\/i><\/b><\/p>\n

\u853c\u7766\u533b\u7597\u8054\u7cfb\u4eba
<\/i>Dominic Chu<\/span>
\u4f01\u4e1a\u8d22\u52a1\u526f\u603b\u76d1
Dominic.chu@affamed.com<\/a>
+852 2912 9004<\/p>\n

VistaGen \u8054\u7cfb\u4eba
<\/i>Mark Flather<\/span>
VistaGen Therapeutics \u6295\u8d44\u8005\u5173\u7cfb\u526f\u603b\u88c1
(650) 577-3617
mflather@vistagen.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u53cc\u65b9\u8ba1\u5212\u4e8e 2022 \u5e74\u4e0b\u534a\u5e74\u542f\u52a8 PH94B \u7528\u4e8e\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u793e\u4ea4\u7126\u8651\u969c\u788d (SAD) \u7684\u5168\u7403\u7814\u7a76 \u8bd5\u9a8c\u65e8\u5728\u652f\u6301 PH94B \u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u4ee5\u5916\u5176\u4ed6\u5e02\u573a\u7684\u5546\u4e1a\u5316 \u4e0a\u6d772022\u5e744\u670813\u65e5 \/\u7f8e\u901a\u793e\/ — VistaGen Therapeutics, Inc. (\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aVTGN\uff09(VistaGen) \u548c\u853c\u7766\u533b\u7597\uff08AffaMed Therapeutics\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u53cc\u65b9\u5df2\u7ecf\u5b8c\u6210\u76f8\u5173\u51c6\u5907\u5de5\u4f5c\uff0c\u5373\u5c06\u542f\u52a8\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u7684 PALISADE \u5168\u7403\u4e09\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u4ee5\u8bc4\u4f30 PH94B\uff08\u853c\u7766\u533b\u7597 AM005\uff09\u6025\u6027\u7ed9\u836f\u6cbb\u7597\u793e\u4ea4\u7126\u8651\u969c\u788d (SAD) \u6210\u4eba\u60a3\u8005\u65f6\u7684\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u3002\u7814\u7a76\u8bbe\u8ba1\u57fa\u4e8e VistaGen \u6b63\u5728\u7f8e\u56fd\u8fdb\u884c\u7684 PH94B PALISADE-1 \u548c PALISADE-2 \u4e09\u671f\u7814\u7a76\u3002PALISADE \u5168\u7403\u7814\u7a76\u7684\u4e3b\u8981\u76ee\u7684\u662f\u4e3a PH94B \u5728\u4e2d\u56fd\u548c\u7f8e\u56fd\u4ee5\u5916\u5176\u4ed6\u5e02\u573a\u7684\u6f5c\u5728\u5546\u4e1a\u5316\u63d0\u4f9b\u652f\u6301\u3002 \u57fa\u4e8e PH94B \u73b0\u6709\u9488\u5bf9 SAD \u7684\u65b0\u836f\u7814\u7a76 (IND) \u7533\u8bf7\uff0cVistaGen \u6700\u8fd1\u5411\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40 (FDA) \u63d0\u4ea4\u4e86 PALISADE \u5168\u7403\u7814\u7a76\u65b9\u6848\uff1b\u853c\u7766\u533b\u7597\u4e5f\u4e8e\u6b64\u524d\u6536\u5230\u4e86\u4e2d\u56fd\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40 (NMPA) \u5bf9\u5176\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7 (CTA) \u7684\u76d1\u7ba1\u8bb8\u53ef\u3002\u4e2d\u7f8e\u4e24\u5730\u7684\u4e34\u5e8a\u8bb8\u53ef\u5171\u540c\u4e3a 2022 \u5e74\u4e0b\u534a\u5e74\u5728\u7f8e\u56fd\u548c\u4e2d\u56fd\u542f\u52a8 PALISADE \u5168\u7403\u7814\u7a76\u5960\u5b9a\u4e86\u57fa\u7840\u3002\u9664\u6b64\u4e4b\u5916\uff0c\u4e24\u5bb6\u516c\u53f8\u8fd8\u8ba1\u5212\u5728\u52a0\u62ff\u5927\u3001\u58a8\u897f\u54e5\u548c\u97e9\u56fd\u542f\u52a8\u8fd9\u9879\u4e09\u671f\u7814\u7a76\u3002\u4f5c\u4e3a\u4e00\u6b3e\u65e0\u5473\u3001\u5feb\u901f\u8d77\u6548\u7684\u4fe1\u606f\u7d20\u9f3b\u55b7\u5242\uff0cPH94B \u5177\u6709\u72ec\u7279\u7684\u6f5c\u5728\u4f5c\u7528\u673a\u5236\uff0c\u53ef\u7528\u4e8e\u6210\u4eba SAD… Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-67526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/67526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=67526"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/67526\/revisions"}],"predecessor-version":[{"id":67527,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/67526\/revisions\/67527"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=67526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=67526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=67526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}